Dietary quercetin at 0.05% (w/w) reduced body weight gain and improved lipid profiles and cognitive performance in HFFD-fed obese mice, and was associated with gut microbiota remodeling (including increased Akkermansia muciniphila), restored intestinal barrier function, altered serum metabolites, reduced neuroinflammation, and activation of hippocampal PI3K/AKT/GSK3β signaling.
Key Findings
Results
Quercetin supplementation significantly reduced body weight gain in mice fed a high-fat, high-fructose diet (HFFD).
The model was a 10-week C57BL/6 mouse study.
Quercetin was provided as dietary supplementation at 0.05% (w/w).
The abstract reports that the reduction in HFFD-induced body weight gain was significant (P < 0.05).
Results
Quercetin improved serum lipid abnormalities and cognitive performance in HFFD-fed mice.
The abstract states that quercetin 'improved serum lipid abnormalities and cognitive performance'.
The study targeted obesity-related cognitive impairment induced by HFFD.
The abstract gives no specific values for lipid parameters or behavioral tests.
Results
Quercetin reshaped gut microbiota composition and notably increased Akkermansia muciniphila.
The conclusion came from integrated multi-omics analysis.
Quercetin was also reported to restore intestinal barrier function.
Results
Quercetin regulated serum metabolite profiles, which the authors link to the gut microbiota changes.
Serum metabolomics was part of the integrated multi-omics analysis.
The authors propose a regulatory axis linking dietary quercetin, gut microbiota, serum metabolites, and hippocampal insulin signaling.
Results
Quercetin activated the hippocampal PI3K/AKT/GSK3β signaling pathway.
Phosphorylated PI3K increased by 46%.
Phosphorylated Akt increased by 49%.
Phosphorylated GSK-3β increased by 50%.
Results
Quercetin suppressed neuroinflammation and inhibited abnormal tau phosphorylation and neuronal apoptosis.
These effects were described as following the gut microbiota, barrier, and serum metabolite alterations.
The abstract reports no quantitative values for inflammatory, tau, or apoptosis markers.
Conclusions
The authors propose an integrated microbiota-gut-brain regulatory axis through which quercetin acts in obesity-related cognitive impairment.
The axis links dietary quercetin, gut microbiota, serum metabolites, and hippocampal insulin signaling.
The authors describe this as providing novel mechanistic insights into quercetin in neuro-metabolic diseases.
What This Means
This study in mice examined whether quercetin, a plant compound found in many fruits and vegetables, could protect against the memory and thinking problems that accompany obesity. Mice were fed a high-fat, high-fructose diet for 10 weeks, and some also received quercetin at 0.05% of their diet. Quercetin reduced weight gain, improved blood lipid levels, and improved cognitive performance.
The researchers also looked at possible mechanisms. Quercetin changed the gut bacteria, including increasing Akkermansia muciniphila, and restored the integrity of the gut barrier. It also changed blood metabolites. In the brain's hippocampus, there was less inflammation, greater activity of the PI3K/AKT/GSK3β insulin-related signaling pathway (increases of about 46–50% in phosphorylated forms of these proteins), and less abnormal tau phosphorylation and nerve cell death.
This research suggests quercetin may influence brain health in obesity through the gut-brain connection. However, the work was done in mice, and the abstract describes associations across multiple measures, so it does not show that quercetin would have the same effects in people. Human studies would be needed to test that.
Li W, Pei Y, Wang J, Zhang J, Zhang W, Jiang X, et al.. (2026). Quercetin Ameliorates Cognitive Impairment in Obese Mice by Activating the PI3K/AKT/GSK3β Signaling Pathway via the Microbiota-Gut-Brain Axis.. Journal of agricultural and food chemistry. https://doi.org/10.1021/acs.jafc.6c04686